Zevra Therapeutics, Inc. - Common Stock (NQ: ZVRA )
7.130
+0.140
(+2.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
All News about Zevra Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks With Whale Alerts In Today's Session
Today 13:35 EDT
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/08/13/earnings_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/09/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/05/Kellanova.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Zevra Therapeutics: Q4 Earnings Insights
March 28, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Zevra Therapeutics
March 27, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Zevra Therapeutics's Earnings: A Preview
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/08/05/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
July 23, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/07/18/Stocks-Photo-by-WHYFRAME-on-Shutterstock.jpeg?width=1200&height=800&fit=crop)
Insiders Buying Zevra Therapeutics And 1 Other Stock
July 18, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/07/17/Stocks-Photo-by-Jirapong-Manustrong-on-S_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Zevra Therapeutics's Earnings: A Preview
August 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/07/09/zvra.png?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/28/microsoft_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
InvestorNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director
October 10, 2023
Topics
Retirement
Exposures
Pension
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/31/acer.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.